CAS: 251356-45-3
Brand | Product data | Purity | Price range | Estimated delivery |
---|---|---|---|---|
SU 16f REF: AN-AG00C4IJCAS: 251356-45-3 | ≥98%(HPLC) | 299.00 €~1,699.00 € | Thu 02 May 24 | |
SU16f REF: TM-T16947CAS: 251356-45-3 | 98% | 74.00 €~711.00 € | Fri 03 May 24 | |
PDGFR Tyrosine Kinase Inhibitor VII REF: 3D-BKA35645CAS: 251356-45-3 | Min. 95% | To inquire | Thu 13 Jun 24 |
Ref: AN-AG00C4IJ
5mg | 299.00 € | |
10mg | 503.00 € | |
25mg | 1,004.00 € | |
50mg | 1,699.00 € |
Estimated delivery in United States, on Thursday 2 May 2024
SU16f
CAS:251356-45-3
SU16f (3-substituted indolin-2-one 16f) is a potent and selective PDGFRβ inhibitor (IC50s: 10 nM, 140 …
Formula:
C24H22N2O3
Purity:
98%
Color and Shape:
Solid
Molecular weight:
386.44
Ref: TM-T16947
1mg | 74.00 € | |
5mg | 143.00 € | |
10mg | 200.00 € | |
25mg | 334.00 € | |
50mg | 495.00 € | |
100mg | 711.00 € | |
1ml*10 (DMSO) | 161.00 € |
Estimated delivery in United States, on Friday 3 May 2024
PDGFR Tyrosine Kinase Inhibitor VII
CAS:251356-45-3
PDGFR Tyrosine Kinase Inhibitor VII is a protein-based drug that binds to the PDGFR tyrosine …
Formula:
C24H22N2O3
Purity:
Min. 95%
Molecular weight:
386.44 g/mol
Ref: 3D-BKA35645
5mg | To inquire | |
10mg | To inquire | |
25mg | To inquire | |
50mg | To inquire | |
100mg | To inquire |
Estimated delivery in United States, on Thursday 13 Jun 2024